Hangzhou Tian-Mu-Shan Pharmaceutical Enterprise Co.,Ltd. Posted 16.4 Million Yuan Net Loss in First Three Quarters of 2021

Hangzhou Tian-Mu-Shan Pharmaceutical Enterprise Co.,Ltd. (杭州天目山药业股份有限公司) (600671.SH) reported a net loss of 16.4 million yuan in the first three quarters of 2021, widening 257.8% year-on-year.

Meanwhile, the company posted 99.8 million yuan in revenue, down 37.7% year-on-year.

At the end of the reporting period, it had 418.9 million yuan in total assets and 342 million yuan in total liabilities, with a liability-to-asset ratio of 81.6%.

This article was automatically produced by Caixin Automation on Nov. 3, 2021.

Download our app to receive breaking news alerts and read the news on the go.

Follow the Chinese markets in real time with Caixin Global’s new stock database.